Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David Goldgar

Showing results (1-10 of 75) with videos related to

Pageof 8
Sort By:
BMC Genetics|February 3, 2006
Linkage analysis of complex diseases using microsatellites and single-nucleotide polymorphisms: application to alcoholismJérémie Nsengimana, Hélène Renard, David Goldgar
Journal of Medical Genetics|August 4, 2007
BRCA phenocopies or ascertainment bias?David Goldgar, Vickie Venne, Tom Conner, et al.
Genetic Epidemiology|September 25, 2004
Increased power for case-control studies of single nucleotide polymorphisms through incorporation of family history and genetic constraintsDeborah Thompson, John S Witte, Martha Slattery, et al.
Human Heredity|November 14, 2003
Haplotype tagging single nucleotide polymorphisms and association studiesDeborah Thompson, Dan Stram, David Goldgar, et al.
American Journal of Medical Genetics. Part A|February 3, 2004
A 23-year-old woman with Down syndrome, type 1 neurofibromatosis, and breast carcinomaDaniel Satgé, Annie J Sasco, David Goldgar, et al.
Psycho-Oncology|March 4, 2011
Influence of the family cluster effect on psychosocial variables in families undergoing BRCA1/2 genetic testing for cancer susceptibilityJulie Lapointe, Belkacem Abdous, Stéphanie Camden, et al.
JCO Precision Oncology|February 1, 2022
Comparison of Somatic and Germline Variant Interpretation in Hereditary Cancer GenesEmily W Moody, Jennie Vagher, Whitney Espinel, et al.
Archives of Dermatology|March 21, 2012
A randomized trial of the off-label use of imiquimod, 5%, cream with vs without tazarotene, 0.1%, gel for the treatment of lentigo maligna, followed by conservative staged excisionsMark A Hyde, Michael L Hadley, Payam Tristani-Firouzi, et al.
European Journal of Medical Genetics|January 1, 2013
Haplotype analysis and ancient origin of the BRCA1 c.4035delA Baltic founder mutationRamūnas Janavičius, Vilius Rudaitis, Bing-Jian Feng, et al.
Experimental and Molecular Pathology|May 23, 2008
Likelihood ratios to assess genetic evidence for clinical significance of uncertain variants: hereditary hemorrhagic telangiectasia as a modelPinar Bayrak-Toydemir, Jamie McDonald, Rong Mao, et al.
Pageof 8

Showing results (1-10 of 75) with videos related to

Sort By:
Pageof 8
BMC Genetics|February 3, 2006
Linkage analysis of complex diseases using microsatellites and single-nucleotide polymorphisms: application to alcoholismJérémie Nsengimana, Hélène Renard, David Goldgar
Journal of Medical Genetics|August 4, 2007
BRCA phenocopies or ascertainment bias?David Goldgar, Vickie Venne, Tom Conner, et al.
Genetic Epidemiology|September 25, 2004
Increased power for case-control studies of single nucleotide polymorphisms through incorporation of family history and genetic constraintsDeborah Thompson, John S Witte, Martha Slattery, et al.
Human Heredity|November 14, 2003
Haplotype tagging single nucleotide polymorphisms and association studiesDeborah Thompson, Dan Stram, David Goldgar, et al.
American Journal of Medical Genetics. Part A|February 3, 2004
A 23-year-old woman with Down syndrome, type 1 neurofibromatosis, and breast carcinomaDaniel Satgé, Annie J Sasco, David Goldgar, et al.
Psycho-Oncology|March 4, 2011
Influence of the family cluster effect on psychosocial variables in families undergoing BRCA1/2 genetic testing for cancer susceptibilityJulie Lapointe, Belkacem Abdous, Stéphanie Camden, et al.
JCO Precision Oncology|February 1, 2022
Comparison of Somatic and Germline Variant Interpretation in Hereditary Cancer GenesEmily W Moody, Jennie Vagher, Whitney Espinel, et al.
Archives of Dermatology|March 21, 2012
A randomized trial of the off-label use of imiquimod, 5%, cream with vs without tazarotene, 0.1%, gel for the treatment of lentigo maligna, followed by conservative staged excisionsMark A Hyde, Michael L Hadley, Payam Tristani-Firouzi, et al.
European Journal of Medical Genetics|January 1, 2013
Haplotype analysis and ancient origin of the BRCA1 c.4035delA Baltic founder mutationRamūnas Janavičius, Vilius Rudaitis, Bing-Jian Feng, et al.
Experimental and Molecular Pathology|May 23, 2008
Likelihood ratios to assess genetic evidence for clinical significance of uncertain variants: hereditary hemorrhagic telangiectasia as a modelPinar Bayrak-Toydemir, Jamie McDonald, Rong Mao, et al.
Pageof 8